Maynard Um
-
-
-
-
-
-
-
Rodman & Renshaw Starts Zentalis Pharmaceuticals (ZNTL) at Buy
-
-
-
-
-
-
-
Zentalis selects 400mg dose for azenosertib ovarian cancer trials
-
-
-
-
-
-
-
Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q3 EPS by 16c
-
-
-
-
-
-
-
Zentalis Pharmaceuticals (ZNTL) Files $250M Mixed Shelf
-
-
-
-
-
-
-
Zentalis Pharmaceuticals (ZNTL) Announces Management Appointments
-
-
-
-
-
-
-
Morgan Stanley Downgrades Zentalis Pharmaceuticals (ZNTL) to Equalweight
-
-
-
-
-
471,052 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


